Implementation outcome | Outcome source | Application to implementation of GAP | Data source |
---|---|---|---|
Context± | Steckler and Linnan (2002) [28]; CFIR [27]; Pfadenhauer (2012) — for granularity of context [29] | Qualitative data collection instruments incorporated CFIR implementation domains and associated constructs [27]; framework analysis of macro, meso and micro context conducted using the CICI framework [29] | Semi-structured interviews with lead clinicians and frontline staff |
Fidelity | Steckler and Linnan (2002) [28] | Adherence to GAP provider training requirement that 75% of staff from each professional group (midwives, sonographers, obstetricians) were trained using both (i) face-to-face and (ii) e-learning methods | Staff training records from the GAP provider |
Degree of concordance to Perinatal Institute guideline assessed as follows: Low: partial or no inclusion of Perinatal Institute’s (PI) recommendations throughout the guidelines, affecting over half of the recommendations. Medium: Moderately concordant with partial or no inclusion of PI’s recommendations in less than half of the recommendations High: Very concordant with only occasional differences where PI’s recommendations were partially included | Local clinical guidelines on screening for foetal growth anomalies | ||
Proportion of women correctly risk stratified (according to GAP) | Review of the maternity records of 600 women who gave birth during the trial period (40 from each of December 2018, January and February 2019 in each cluster) | ||
Reach | Steckler and Linnan (2002) [28] | Proportion of women with a GAP-GROW chart in the notes | Maternity records review (see above) |
Dose delivered and received | Steckler and Linnan (2002) [28] | Proportion of low-risk women* who had at least the minimum expected fundal height measurements performed and plotted on the chart | Maternity records review (see above) |
Proportion of low-risk women* referred for growth scan when indicated | |||
Proportion of high-risk women* who had at least the minimum expected growth scans performed and plotted on the chart | |||
Implementation strength | Schellenberg et al. (2021) [30] | Combined assessment of fidelity, dose and reach | |
Acceptability | Proctor et al. (2011) [31] | Acceptability of GAP implementation from the perspectives of clinicians | Semi-structured interviews with lead clinicians and frontline staff |
Feasibility | Proctor et al. (2011) [31] | The degree to which GAP implementation is feasible, from the perspectives of interview participants |